NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

today announced that an abstract highlighting data supporting the immune component of amezalpat’s purported mechanism of action has been accepted for poster presentation at the 2025 American ...

About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

Enrollment ongoing in Phase 2 KOURAGE trial of AuxoraTM in acute kidney injury (AKI) and respiratory failure; data expected around the end of 2025 ...

Global Opportunities Trust Plc - Annual Results PR Newswire LONDON, United Kingdom, April 04 Global Opportunities Trust plcLegal Entity Identifier: 2138005T5CT5ITZ7ZX58 ...

Creative teams love a big reveal,” creative director Dionysis Livanis pointed out recently. “Clients? Not so much.” Writing ...

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) and respiratory failure; data expected around the end of 2025 Post-hoc analysis of ...

This week’s Edmonds City Council meeting, while short on action items, was taken up with a series of reports providing ...

An announcement from Evaxion Biotech ( ($EVAX) ) is now available. Evaxion Biotech A/S has announced its Annual General Meeting to be held on ...

Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform TM provides ...

Imperial’s 30% share of revenue from the Red Chris mine in 2024 was $190.0 million compared to $109.8 million in 2023, an increase of $80.2 million. In 2024, the Red Chris mine (100% basis) had 19 ...